Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Hereditary paraganglioma syndrome has recently been shown to be caused by germline heterozygous mutations in three (SDHB, SDHC, and SDHD) of the four genes that encode mitochondrial succinate dehydrogenase. Extraparaganglial component neoplasias have never been previously documented. In a population-based registry of symptomatic presentations of phaeochromocytoma/paraganglioma comprising 352 registrants, among whom 16 unrelated registrants were SDHB mutation positive, one family with germline SDHB mutation c.847-50delTCTC had two members with renal cell carcinoma (RCC), of solid histology, at ages 24 and 26 years. Both also had paraganglioma. A registry of early-onset RCCs revealed a family comprising a son with clear-cell RCC and his mother with a cardiac tumor, both with the germline SDHB R27X mutation. The cardiac tumor proved to be a paraganglioma. All RCCs showed loss of the remaining wild-type allele. Our observations suggest that germline SDHB mutations can predispose to early-onset kidney cancers in addition to paragangliomas and carry implications for medical surveillance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, clinical similarities besides pheochromocytoma have been noted in families with germline mutations of VHL and SDHB [26].”
From A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas (2005) · cites this paper as [26]
Citations
Cites
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 3×
“00 cinate dehydrogenase (SDH), were described in families with head and neck PGLs (Baysal et al. 2000).”
BackgroundInfluentialThe Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635 · cited 6×
“It is interesting that germline FH mutations are associated with HLRCC (Tomlinson et al. 2002).”
BackgroundInfluentialOhh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Self-citationNickerson, M. L., Warren, M. B., Toro, J. R., Matrosova, V., Glenn, G., Turner, M. L., Duray, P., Merino, M., Choyke, P., Pavlovich, C. P., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00104-6 · Cited by 940 · cited 2×
“Germline mutations in HRPT2 have been recently associated with hyperparathyroidism jaw tumor syndrome (MIM 145001), and germline mutations in BHD, encoding folliculin, have been associated with Birt-Hogg-Dubé syndrome (MIM 135150); both of these diseases have RCC as component tumors (Khoo et al. 2002; Nickerson et al.…”
BackgroundChen, F., Kishida, T., Yao, M., Hustad, T., Glavac, D., Dean, M., Gnarra, J. R., Orcutt, M. L., Duh, F. M., Glenn, G., et al. (1995) · Human Mutation · doi:10.1002/humu.1380050109 · Cited by 556
Activating mutations for the Met tyrosine kinase receptor in human cancer
Jeffers, M., Schmidt, L., Nakaigawa, N., Webb, C. P., Weirich, G., Kishida, T., Zbar, B., & Vande Woude, G. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11445 · Cited by 442 · cited 4×
“Accumulation of reactive oxygen species could result from dysfunction in mitochondrial energy metabolism; results supporting this theory have been reported (Jeffers et al. 1997; Eng et al. 2003).”
BackgroundResultInfluentialA role for mitochondrial enzymes in inherited neoplasia and beyond
Eng, C., Kiuru, M., Fernandez, M. J., & Aaltonen, L. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1013 · Cited by 392 · cited 10×
“It is interesting that germline mutations in genes encoding two other subunits of SDH (mitochondrial complex II), SDHB (MIM 185470 and MIM 605373) and SDHC (MIM 602413), were found to be associated with heritable pheochromocytoma and/or PGL (Maher and Eng 2002; Eng et al. 2003).”
BackgroundResultInfluentialSelf-citation
Cited by
Items 301–387 of 387
Immunoexpression of SDHB, FH, and CK20 among eosinophilic renal tumors: A tissue microarray study
Karatay, H., Özlük, Y., Doğan, M. A., Erdem, S., & Kiliçaslan, İ. (2021) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2021.151788 · Cited by 3
Mitochondria-Mediated Oxidative Stress and Cancer Therapy
Ahmad, I. M., & Abdalla, M. Y. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-397-4_1 · Cited by 3
Sato, H., Shoji, S., Kajiwara, H., Itoh, J., & OSAMURA, R. Y. (2013) · Endocrine Pathology · doi:10.1007/s12022-013-9252-0 · Cited by 3
Association of mitochondrial disorders with lymphoid malignancies
Mende, S., Koch, R., Schmiedel, J., Reichmann, H., & Storch, A. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.08.003 · Cited by 3
Molecular Characterization of Renal Cell Carcinoma
Teh, B. T., Farber, L. J., & Furge, K. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2400-0_5 · Cited by 3
Hereditary Renal Cell Carcinoma
Baba, M., Schmidt, L. S., & Linehan, W. M. (2017) · Springer eBooks · doi:10.1007/978-4-431-55531-5_2 · Cited by 4
de Vos, B., Rijken, J. A., Adank, M. A., Hoksbergen, A. W. J., Bayley, J., Leemans, C. R., & Hensen, E. F. (2018) · Clinical Otolaryngology · doi:10.1111/coa.13059 · Cited by 3
“It is now known that SDHx germline variants do not only predispose to PGL/PHEO, but also to non-paraganglionic tumours such as gastrointestinal stromal tumours, renal cell carcinomas and pituitary adenomas.(8-10) The complete spectrum of the SDHB-linked phenotype has, however, not yet been fully elucidated, because th…”
BackgroundClinicopathologic features of succinate dehydrogenase deficiencient renal cell carcinoma.
Zhu, Q., Wu, X., Huang, Y., Tang, M., & Wu, L. (2020) · PubMed Central · Cited by 3
Germline Cancer Susceptibility Variants in Patients With Uveal Melanoma
Repo, P. E., Jakkula, E., Hiltunen, J., Putkuri, H., Staskiewicz, A., Järvinen, R., Täll, M., Raivio, V., Al‐Jamal, R. T., Kivelä, T., et al. (2025) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.70041 · Cited by 2
“Pathogenic SDHA variants predispose to paragangliomas, pheochromocytomas, and RCC, albeit with lower penetrance than SDHB variants (MacFarlane et al. 2020; Maniam et al. 2018).”
InfluentialProkaryotic organelle mitochondria drive tumorigenesis: “the original sin”
Wang, C., Luo, M., Zhou, J., Zhang, Q., Xiawei, J., He, J., Wang, L., Huang, Y., Xu, X., & 王方岩 (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1632702 · Cited by 5
Wilfinger‐Lutz, N., Kührer, K., Bueno, M. J., Schwaiger-Haber, M., Wang, W., Krejci, K., Mekis, R., Erünlü, N. G. O., Miller, A., Junza, A., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108087 · Cited by 2
Moch, H. (2012) · Der Pathologe · doi:10.1007/s00292-012-1683-8 · Cited by 2
Management of Locally Advanced and Metastatic Pheochromocytoma and Paraganglioma
Román-Gonzaléz, A., Vásquez, P. J., Hyde, S. M., Jessop, A., & Jiménez, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_15 · Cited by 2
Bersang, A. B., Bube, S. H., Fode, M. M., & Azawi, N. (2018) · Journal of Endourology Case Reports · doi:10.1089/cren.2017.0140 · Cited by 2
“SDH has an important role in cellular energy metabolism in the Krebs cycle and as part of the respiratory chain.(1) Vanharanta et al.”
Callender, G. G., Rich, T. A., Lee, J. E., Perrier, N. D., & Grubbs, E. G. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-997-0_13 · Cited by 2
Yanus, G. A., Iyevleva, A. G., Suspitsin, E. N., Tumakova, A. V., Белогубова, Е. В., Алексахина, С. Н., Togo, A. V., & Имянитов, Е. Н. (2023) · Sechenov Medical Journal · doi:10.47093/2218-7332.2023.14.2.5-20 · Cited by 5
“Мутации могут локализоваться в генах различных субъединиц этого фермента SDHA/B/C/D/ AF2, (succinate dehydrogenase complex flavoprotein subunit A, B, C, D, AF2), “SDHx”, однако в подавляющем большинстве случаев РП ассоциирован с наследственными повреждениями SDHB [60, 61].”
InfluentialPheochromocytoma and Paraganglioma
Corssmit, E. P. M., & van Hulsteijn, L. T. (2024) · Springer eBooks · doi:10.1007/978-3-031-56968-5_25 · Cited by 2
Graham, D., Gooch, M., Ye, Z., Richer, E. J., Chishti, A. S., Reilly, E. A., & D'Orazio, J. A. (2014) · Case Reports in Genetics · doi:10.1155/2014/273423 · Cited by 2
“Critically, we have referred her immediate family for formal genetic evaluation to screen for SDHB mutations and to provide genetic counseling regarding the implications of the patient’s identified cancer syndrome.”
BackgroundNeumann, H. P. H. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0528 · Cited by 2
Self-citationErkan, S., Somner, J., & Rajan, G. P. (2016) · Journal of Neurological Surgery Reports · doi:10.1055/s-0036-1579629 · Cited by 2
Succinate detection in glomus jugulare paraganglioma on MRS as a marker for SDHB mutation
Naganawa, S., Capizzano, A. A., Ota, Y., Kim, J., Srinivasan, A., & Moritani, T. (2020) · Otolaryngology Case Reports · doi:10.1016/j.xocr.2020.100207 · Cited by 2
Paraganglioma and Pheochromocytoma
Iacobone, M., & Torresan, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-62241-1_15 · Cited by 2
Mitochondrial-to-Nuclear Communications in Cancer
Dakubo, G. D. (2010) · Springer eBooks · doi:10.1007/978-3-642-11416-8_4 · Cited by 2
Neumann, H. P. H., & de Herder, W. W. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0340 · Cited by 3
“This was shown for the VHL gene (Neumann & Zbar 1997, Ebele et al. 2004), the SDHB gene (Vanharanta et al. 2004, Ricketts et al. 2008, Gill et al. 2011a,b), the SDHC gene (Malinoc et al. 2012) and the SDHD gene (Ricketts et al. 2012) in clear cell renal cancer http://joe.endocrinology-journals.org…”
BackgroundSelf-citationMOLECULAR AND CLINICAL CHARACTERISTICS OF TRICARBOXYLIC ACID CYCLE-ASSOCIATED TUMORS
Lehtonen, H. J. (2008) · Helda - University of Helsinki Institutional Repository · Cited by 2
The Role Of Fumarase (FH) In Tumorigenesis
Lehtonen, R. (2006) · Helda - University of Helsinki Institutional Repository · Cited by 2
Self-citationThe 3PAs syndrome and succinate dehydrogenase deficiency in pituitary tumors
Xekouki, P., Daraki, V. N., Betsi, G., Chrysoulaki, M., Sfakiotaki, M., Mytilinaiou, M. G., & Stratakis, C. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814537-1.00001-4 · Cited by 1
Liu, X., Liu, J., Hu, J., Hu, Y., Liu, Y., & Cheng, M. (2025) · International Journal of Surgical Pathology · doi:10.1177/10668969251363981 · Cited by 1
French recommendations on multi-gene panel testing in renal cell carcinoma.
Giraud, S., Berthet, P., Abadie, C., Andrieu, N., Benusiglio, P., Bonadona, V., Caron, O., Corsini, C., Coupier, I., Crivelli, L., et al. (2025) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2025.105062 · Cited by 1
Biomarker für Nierenkarzinome : Was ist gerechtfertigt?
Moch, H. (2012) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-65467 · Cited by 1
Can Mutations in the BAP1 Gene be Detected by Immunohisto-chemistry in Hereditary Kidney Cancers?
Ghosh, A., Lara‐Otero, K., Linehan, W. M., & Merino, M. J. (2014) · Journal of Analytical Oncology · doi:10.6000/1927-7229.2014.03.03.3 · Cited by 1
“The SDHB associated renal tumors cell, show a characteristic appearance that mimics oncocytomas [15-17].”
BackgroundFeocromocitoma y paraganglioma hereditario: la enfermedad de las 10 caras
Cascón, A., & Robledo, M. (2013) · Medicina Clínica · doi:10.1016/j.medcli.2012.12.009 · Cited by 1
Timmers, H. J. L. M., & Pacák, K. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.3.399 · Cited by 1
Immunohistochemistry as a tool for screening rare renal cancers
Yong, C., Stewart, G. D., & Frezza, C. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.10.18 · Cited by 1
Hereditary renal cell tumors: Clinicopathologic importance
Singh, H., Divatia, M. K., Baek, D., & Ro, J. Y. (2021) · annals of urologic oncology · doi:10.32948/auo.2021.10.15 · Cited by 2
Non-Wilms Pediatric Renal Tumors
Dome, J. S., Gooskens, S. L. M., & van den Heuvel‐Eibrink, M. M. (2014) · Pediatric oncology · doi:10.1007/978-3-662-44003-2_14 · Cited by 1
Hereditary Renal Cell Carcinoma
Dawsey, S. J., & Gupta, S. (2022) · Kidney Cancer · doi:10.3233/kca-210008 · Cited by 2
“SHDBRCC was first described in 2004 in a kindred study of 2 families in which there was RCC diagnosed with age of onset < 30 years old and variable histology with solid, clear cell, and cells with granular eosinophilic cytoplasm [110].”
BackgroundSuccinate dehydrogenase deficient renal cell carcinoma: A case report of an uncommon renal cancer
Kodare, D., Menon, S. G., Prakash, G. J., & Desai, S. B. (2024) · Indian Journal of Cancer · doi:10.4103/ijc.ijc_801_21 · Cited by 1
Familial Renal Cell Cancers and Pheochromocytomas
Chan-Smutko, G., & Iliopoulos, O. (2010) · Springer eBooks · doi:10.1007/978-0-387-93846-2_9 · Cited by 1
Waguespack, S. G., & Fishbein, L. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00015-4 · Cited by 11
MacLennan, G. T., & Liang Cheng, C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-54941-7.00002-5 · Cited by 4
Ojukwu, D. I., & Galgano, M. A. (2022) · Operative Neurosurgery · doi:10.1227/ons.0000000000000423 · Cited by 1
Feocromocitoma asociado a síndrome paraganglionar
Tejero, M. L. M., Trevejo, M. P., Ruiz, C. M., & Gómez, E. G. (2008) · Anales de Pediatría · doi:10.1157/13120057 · Cited by 1
de Velasco, G., Signoretti, S., Rini, B. I., & Choueiri, T. K. (2017) · doi:10.1002/9781119196235.ch4 · Cited by 1
An investigation of the effect of some stable nitroxide antioxidants in prostate cancer cells
Eng, G. T. A. (2015) · QUT ePrints (Queensland University of Technology) · Cited by 1
Hereditary Pheochromocytoma and Multiple Endocrine Neoplasia Type 2 (MEN2)
Rich, T. A., Jiménez, C., & Evans, D. B. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374430-2.00017-1
Genetics, epigenetics and angiogenesis in renal cell carcinoma
Baldewijns, M. M. L. L. (2009) · Research Publications (Maastricht University) · doi:10.26481/dis.20090626mb
Hereditary Renal Tumors of the Adult
Spruijt, L., & Hoogerbrugge, N. (2008) · Wiley eBooks · doi:10.1002/9783527627523.ch15
Pheochromocytoma and Paraganglioma
Corssmit, E. P. M., & van Hulsteijn, L. T. (2015) · Springer eBooks · doi:10.1007/978-3-662-45215-8_24
The enzyme succinate dehydrogenase (SDH) and its role in hereditary pituitary adenomas
Панкратова, Ю. В., Przhiyalkovskaya, E. G., Pigarova, E. A., & Dzeranova, L. K. (2013) · Obesity and metabolism · doi:10.14341/omet2013410-15
Biomarkers for Prognosis and Molecularly Targeted Therapy in Renal Cell Carcinoma
Schmidt, L. S. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-615-9_11
Orloff, M. S., & Eng, C. (2009) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(09)79232-x
Self-citationRenal Carcinoma and von H ippel– L indau Disease
Connor, T. M. F., & Maxwell, P. H. (2018) · Wiley eBooks · doi:10.1002/9780470015902.a0006062.pub3
Ghazi, A. A., Khah, A. M., Kamani, F., Zare, K., Sadeghipour, A., Hedayati, M., Yeganeh, M. Z., Cranston, T., & Grossman, A. B. (2014) · HORMONES · doi:10.14310/horm.2002.1500
Timmers, H. J. L. M., Gimenez‐Roqueplo, A., Mannelli, M., & Pacák, K. (2009)
Holmes, P., Curtis, M. T., & Miettinen, M. (2014) · Pathology Case Reviews · doi:10.1097/pcr.0000000000000026
Timmers, H. J. L. M., Kozupa, A., Eisenhofer, G., Raygada, M. J., Adams, K. T., Solis, D. C., Lenders, J. W. M., & Pacák, K. (2007)
Oncocytome, tumeur hybride, carcinome chromophobe
Compérat, É. (2014) · Elsevier eBooks · doi:10.1016/b978-2-294-73736-7.00007-0
Revista del Ilustre Colegio Ofi cial de Médicos de Teruel
Ángel, J., Padilla, J. S., Sebas, S., Lamarca, P. I. B., Yago, B. S., Royo, F. G., & Torbey, M. N. (2013) · Dialnet (Universidad de la Rioja)
Molecular Genetics of Pheochromocytoma and Paraganglioma
Robledo, M., Currás-Freixes, M., & Cascón, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-46038-3_2
Medizin, A. I., Freiburg, U., Innere, A., Radiologie, A. A., Klinik, H.-N.-O., Klinik, N., & Nuklearmedizin, A. (2012)
KLLN as Tumor Suppressor in Cowden Syndrome and Sporadic Breast Cancers
Nizialek, E. A. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
Type 2B von Hippel-Lindau disease: molecular biology, tumor growth, and development
Lee, C. M. (2009) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/29tv-bb60
Hereditary Syndromes Associated with Kidney Tumors
Özcan, A., Erdoğan, Ş., & Truong, L. D. (2019) · Springer eBooks · doi:10.1007/978-3-030-28333-9_11
Major Subtypes of Renal Cell Carcinoma
Divatia, M. K., Guo, C. C., Rehman, A. U., & Ro, J. Y. (2019) · Springer eBooks · doi:10.1007/978-3-030-28333-9_5
Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling
Webster, R. D., Bannon, S. A., Hyde, S. M., Woodson, A., You, N., Lu, K. H., & Arun, B. (2019) · Wiley eBooks · doi:10.1002/9781119000822.hfcm143
遺伝性腎細胞癌とその患者会活動 − VHL 病患者会を中心にして−
太郎, 執., 真吾, 蘆., 山崎一郎, 賢司, 田., & 雅行, 鎌. (2005) · doi:10.18976/jsft.5.1_8
Mitochondrial DNA (mtDNA) and Cancer Pathogenesis – The Role of mtDNA Mutations: A Review
Chrysanthakopoulos, N. A. (2021) · doi:10.47733/gjccr.2020.2101 · Cited by 1
“Nuclear (n)DNA-encoded mitochondrial gene mutations have been identified in cancer cases (Lehtonen et al., 2004; Astuti et al., 2001; Vanharanta et al., 2004), finding that led to the hypothesis that mtDNA mutations might also be involved in cancer etiology.”
BackgroundSuccinate Dehydrogenase Mutation and Paraganglioma Syndromes: A Review Article
Ramakant, P. (2021) · Indian Journal of Endocrine Surgery and Research · doi:10.5005/jp-journals-10088-11162
Paraganglioma and Pheochromocytoma
Sandberg, A. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-510-7_5
Renal Carcinoma and von Hippel–Lindau Disease
Connor, T. M. F., & Maxwell, P. H. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0006062.pub2
Vasquez, J. C., Singh, C., Bindra, R. S., Glazer, P. M., & Pashankar, F. (2022) · doi:10.22541/au.165544424.41884113/v1
Major heritable renal cell carcinoma syndromes: novel treatment options and future perspectives
Naidoo, V., Perera, M., & Adam, A. (2022) · Current Opinion in Urology · doi:10.1097/mou.0000000000001030
Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling
Bluebond, R., Bannon, S. A., Hyde, S. M., Woodson, A., You, N., Lu, K. H., & Arun, B. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm143.pub2
Stonnington, H. O., Olson, V. A., Kalani, M. A., Krishna, C., Patel, N. P., & Bendok, B. R. (2022) · Operative Neurosurgery · doi:10.1227/ons.0000000000000550
Succinate as an Oncometabolite in Endocrine, Mesenchymal, and Epithelial Tumors
Yazdi, S. A. M., & Nazar, E. (2022) · Iranian Red Crescent Medical Journal · doi:10.32592/ircmj.2022.24.12.2395
Succinate dehydrogenase-deficient renal cell carcinoma: A retrospective study, 1999–2018
Morrison, E., Goedhals, J., Pretorius, S., Joubert, G., Gill, A. J., & van der Westhuizen, G. (2023) · South African Journal of Oncology · doi:10.4102/sajo.v7i0.252
Surgical Management of Hereditary Kidney Cancer Syndromes
Gopal, N., Webster, B. R., Antony, M. B., & Ball, M. W. (2023) · Springer eBooks · doi:10.1007/978-3-031-40901-1_6
Exploring the Role of Mitochondrial DNA Mutations in Cancer Development and Diagnosis
Caldiran, F. Y., & Aydemir, M. N. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_270 · Cited by 2
Investigating the role of mitochondrial energy rewiring throughout prostate cancer progression
Bidgood, C. L. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.248849
[Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: Clinicopathological Analysis of 11 Cases].
Pan, X., Wei, Y., Sui, X., Yin, X., Zheng, L., Zeng, H., Zhou, Q., & Chen, N. (2024) · 四川大学学报:医学版 · doi:10.12182/20240960101 · Cited by 1
张, 烁. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1551556
MacLennan, G. T., & Liang Cheng, C. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4327-8.00002-4 · Cited by 5
Differential Flux-Balance Analysis Infers Metabolic Mutations Associated with Cancer
Pagliarini, R. (2025) · Lecture notes in computer science · doi:10.1007/978-3-032-08452-1_13
Kestel, S., OLGUN, A., Polat, F., Atan, A., Çetin, S., Gönül, İ. I., & Ekinci, Ö. (2026) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2026.1510058
Dayasagar, H., Kumar, H., & John, N. T. (2026) · BMJ Case Reports · doi:10.1136/bcr-2026-274966
Metadata
- Authors
- Vanharanta, S., Buchta, M., McWhinney, S. R., Virta, S. K., Peçzkowska, M., Morrison, C. D., Lehtonen, R., Januszewicz, A., Järvinen, H., Juhola, M., Mecklin, J.-P., Pukkala, E., Herva, R., Kiuru, M., Nupponen, N. N., Aaltonen, L. A., Neumann, H. P. H., & Eng, C.
- Affiliations
- University of Helsinki (FI)
- University of Freiburg (DE)
- The Ohio State University (US)
- Institute of Cardiology (PL)
- Helsinki University Hospital (FI)
- Central Finland Health Care District (FI)
- Finnish Cancer Registry (FI)
- Oulu University Hospital (FI)
- University of Cambridge (GB)
- Corresponding author
- Eng, Charis
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 74
- Issue
- 1
- Pages
- 153-159
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1181902
- OpenAlex
- W1977015709
- Cited by
- 389
- References
- 24
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 14 · 2023: 11 · 2022: 14 · 2021: 20 · 2020: 12 · 2019: 22 · 2018: 16 · 2017: 20 · 2016: 20 · 2015: 21 · 2014: 32 · 2013: 26 · 2012: 29
- FWCI
- 13.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3487 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (NE571/4-1)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD039058, R01 HD39058, R01HD39058-02S1)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- SDHB mutation, hereditary paraganglioma, succinate dehydrogenase, clear cell renal cell carcinoma, cardiac paraganglioma, germline mutations, loss of heterozygosity, cancer susceptibility, medical surveillance
- MeSH terms
- Adolescent, Adult, Base Sequence, Carcinoma, Renal Cell, Female, Humans, Iron-Sulfur Proteins, Kidney Neoplasms, Male, Paraganglioma, Pedigree, Succinate Dehydrogenase, Sequence Deletion, Age of Onset, Germ-Line Mutation, Genetic Predisposition to Disease, Mutation, Missense, Protein Subunits, Siblings
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.